Literature DB >> 26016811

Correlation between visual acuity changes and optical coherence tomography morphological findings in idiopathic epiretinal membranes.

I-Mo Fang1,2, Chih-Chao Hsu3, Li-Li Chen3.   

Abstract

PURPOSE: To analyze the influence of spectral-domain optical coherence tomography (SD-OCT) features on visual acuity changes in patients with idiopathic epiretinal membranes (ERMs).
METHODS: Seventy-nine eyes of 71 patients were included in this study. SD-OCT was performed for all patients; data were collected upon ERM diagnosis and at the final visit. The patients were divided into subgroups based on their SD-OCT features. The initial best corrected visual acuity (BCVA) and changes in BCVA for each subgroup were compared. A multivariate analysis was performed to assess the factors associated with changes in BCVA.
RESULTS: During a mean follow-up period of 20.78 months, the mean change in logMAR visual acuity was 0.052 ± 0.089. Eyes with inner segment/outer segment (IS/OS) junction disruption and cystoid macular edema (CME) had a significantly lower mean initial BCVA than those without disruption and CME (P = 0.036 and P = 0.012, respectively). However, only eyes with CME had significant changes in BCVA (P = .034). Multivariate analysis revealed the presence of CME as the only factor that had a significant correlation with VA changes.
CONCLUSIONS: In patients with idiopathic ERMs, the presence of CME and IS/OS disruption detected by OCT correlated with a poorer initial BCVA. Most patients' visual acuity remained stable during follow-up. The presence of CME with OCT represented a predictor of the progression of visual acuity. These results may provide valuable clinical information regarding the management of patients with idiopathic ERMs. We demonstrated that the presence of CME and IS/OS disruption detected with OCT correlated with a poorer BCVA in idiopathic ERMs. The visual acuity of most patients was stable during the follow-up period. The presence of CME in OCT represented a predictor of vision deterioration for patients with idiopathic ERMs.

Entities:  

Keywords:  Cystoid macular edema; Idiopathic epiretinal membrane; Optical coherent tomography

Mesh:

Year:  2015        PMID: 26016811     DOI: 10.1007/s00417-015-3069-0

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  34 in total

1.  Optical coherence tomography of idiopathic macular epiretinal membranes before and after surgery.

Authors:  P Massin; C Allouch; B Haouchine; F Metge; M Paques; L Tangui; A Erginay; A Gaudric
Journal:  Am J Ophthalmol       Date:  2000-12       Impact factor: 5.258

2.  Optical coherence tomography in idiopathic epiretinal macular membrane surgery.

Authors:  C Azzolini; F Patelli; M Codenotti; L Pierro; R Brancato
Journal:  Eur J Ophthalmol       Date:  1999 Jul-Sep       Impact factor: 2.597

3.  Spectral domain optical coherence tomography: ultra-high speed, ultra-high resolution ophthalmic imaging.

Authors:  Teresa C Chen; Barry Cense; Mark C Pierce; Nader Nassif; B Hyle Park; Seok H Yun; Brian R White; Brett E Bouma; Guillermo J Tearney; Johannes F de Boer
Journal:  Arch Ophthalmol       Date:  2005-12

4.  The impact of optical coherence tomography on surgical decision making in epiretinal membrane and vitreomacular traction.

Authors:  Diana V Do; Minhee Cho; Quan Dong Nguyen; Syed Mahmood Shah; James T Handa; Peter A Campochiaro; Ingrid Zimmer-Galler; Jennifer U Sung; Julia A Haller
Journal:  Trans Am Ophthalmol Soc       Date:  2006

5.  Associations between macular findings by optical coherence tomography and visual outcomes after epiretinal membrane removal.

Authors:  Min Hee Suh; Jong Mo Seo; Kyu Hyung Park; Hyeong Gon Yu
Journal:  Am J Ophthalmol       Date:  2008-12-03       Impact factor: 5.258

6.  Optical coherence tomographic patterns of diabetic macular edema.

Authors:  Brian Y Kim; Scott D Smith; Peter K Kaiser
Journal:  Am J Ophthalmol       Date:  2006-09       Impact factor: 5.258

7.  Epiretinal membranes after extracapsular cataract surgery(1).

Authors:  C E Jahn; V Minich; S Moldaschel; B Stahl; P Jedelhauser; G Kremer; M Kron
Journal:  J Cataract Refract Surg       Date:  2001-05       Impact factor: 3.351

8.  Morphometric spectral-domain optical coherence tomography features of epiretinal membrane correlate with visual acuity in patients with uveitis.

Authors:  Hossein Nazari; Laurie Dustin; Florian M Heussen; Srinivas Sadda; Narsing A Rao
Journal:  Am J Ophthalmol       Date:  2012-04-26       Impact factor: 5.258

9.  Morphologically functional correlations of macular pathology connected with epiretinal membrane formation in spectral optical coherence tomography (SOCT).

Authors:  Janusz Michalewski; Zofia Michalewska; Sławomir Cisiecki; Jerzy Nawrocki
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-05-04       Impact factor: 3.117

10.  Epiretinal membranes in patients with uveitis: morphological and functional analysis with spectral domain optical coherence tomography.

Authors:  Ludovico Iannetti; Paolo Tortorella; Enzo D'Ambrosio; Rossela Spena; Roberta Zito; Magda Gharbiya
Journal:  Biomed Res Int       Date:  2013-11-05       Impact factor: 3.411

View more
  3 in total

1.  The natural course of idiopathic epiretinal membranes with optical coherence tomography follow-up.

Authors:  Ahmet Taylan Yazıcı; Osman Çekiç
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-11-10       Impact factor: 3.117

2.  Correlation between Uncorrected Visual Acuity and Macular Distortion in Idiopathic Epiretinal Membrane Patients.

Authors:  Jang Hoon Lee; Sung Pyo Park; Yong Kyu Kim
Journal:  Korean J Ophthalmol       Date:  2017-11-15

3.  A Novel Approach to Quantitative Evaluation of Outer Retinal Lesions Via a New Parameter "Integral" in Spectral Domain Optical Coherence Tomography.

Authors:  Junxiang Gu; Tingting Jiang; Mingrong Yu; Jian Yu; Wenting Li; Shixue Liu; Peijun Zhang; Wenwen Chen; Qing Chang
Journal:  Transl Vis Sci Technol       Date:  2020-11-02       Impact factor: 3.283

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.